22 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... amphotericin B, 3 to 5 mg/kg ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis #IDSA ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
Peri-operative Hyperthermia - Guidelines for Crises in Anaesthesia
If prolonged or ≥ 39 C this is a
Hyperthermia - Guidelines ... Treatment depends ... Reference Handbook - Guidelines ... Differential #Causes #Anesthesiology ... Checklist #Diagnosis #Management
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... other factors (e.g ... Cytomegalovirus #CMV #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... ., 4 mg/kg on days ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Clostridioides Difficile Infection ... Diagnosis and Management ... (IDSA 2021): ... Bezlotoxumab 10 mg/kg ... Guideline: https
Systemic Inflammatory Response Syndrome (SIRS)
•	Non-specific (infections vs non-infectious)
•	≥2 of the following:
o	Temp >38°C or <36°C
o	HR >90 bpm
o	RR
Inflammatory Response Syndrome ... >2 mmol/L Management ... Sepsis Campaign Guidelines ... recognition & treatment ... fluids (30 mL/kg
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... amphotericin B 3–5 mg/kg ... Coccidiodomycosis #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... acyclovir 5 mg/kg ... • Continue treatment ... #Prevention #Treatment ... #management #opportunistic
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
response preceding infection ... bradycardia, urinary retention ... Treatment: • Plasmapheresis ... #diagnosis #management ... #treatment #neurology